Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,596
Closed -$426K 252
2026
Q1
$426K Sell
1,596
-15,968
-91% -$4.32M ﹤0.01% 230
2025
Q4
$4.41M Buy
17,564
+7,415
+73% +$1.97M 0.05% 95
2025
Q3
$2.91M Buy
+10,149
New +$2.72M 0.04% 138
2023
Q3
Sell
-11,656
Closed -$2.42M 415
2023
Q2
$2.42M Buy
11,656
+3,094
+36% +$600K 0.05% 94
2023
Q1
$1.69M Buy
+8,562
New +$1.76M 0.04% 96
2021
Q2
Sell
-427
Closed -$94K 779
2021
Q1
$94K Sell
427
-540
-56% -$108K ﹤0.01% 591
2020
Q4
$169K Sell
967
-9,675
-91% -$1.67M ﹤0.01% 545
2020
Q3
$1.72M Buy
+10,642
New +$1.69M 0.03% 165
2020
Q2
Sell
-15,873
Closed -$1.72M 625
2020
Q1
$1.72M Buy
15,873
+3,503
+28% +$505K 0.04% 207
2019
Q4
$1.8M Buy
12,370
+3,284
+36% +$474K 0.03% 277
2019
Q3
$1.31M Buy
+9,086
New +$1.33M 0.02% 248
2019
Q1
Sell
-102,665
Closed -$11.1M 303
2018
Q4
$11.1M Buy
+102,665
New +$13.8M 0.16% 76

Other funds holding LH

Lee Ainslie's LH Position: Q2 2026 in Review

Lee Ainslie sold out of Labcorp (LH) in Q2 2026, closing a stake of 1,596 shares — an estimated $426K sold.

Lee Ainslie first reported a position in LH in Q4 2018 and held it in 12 quarters. The position peaked at $11.1M in Q4 2018. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Lee Ainslie reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Lee Ainslie sold 1,596 Labcorp shares in Q2 2026, an estimated $426K.
  • Lee Ainslie first reported a position in Labcorp in Q4 2018 and held it in 12 quarters.
  • Lee Ainslie's Labcorp position peaked at $11.1M in Q4 2018.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.